The selective estrogen receptor modulator, raloxifene: Reproductive assessments following premating exposure in female rats

Reproductive Toxicology

Volumn 12, Issue 3, 1998, Pages 233-245

  Hoyt, Judith A ^a   Fisher, Lawrence F ^a   Buelke Sam, Judy L ^a   Francis, Paul C ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Antifertility; Estrous cycles; Premating effects; Progeny effects; Raloxifene; Rat; Reproduction; SERM

Indexed keywords

ANTIESTROGEN; BENZOTHIOPHENE DERIVATIVE; ESTROGEN RECEPTOR; PIPERIDINE DERIVATIVE; RALOXIFENE;

ANIMAL; ANIMAL MODEL; ARTICLE; BODY WEIGHT; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ESTRUS; ESTRUS CYCLE; EVALUATION; FEMALE; FEMALE FERTILITY; FETUS DEVELOPMENT; FOOD INTAKE; GESTATIONAL AGE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; POSTMENOPAUSE OSTEOPOROSIS; PREGNANCY; RAT; REPRODUCTION; REPRODUCTIVE TOXICITY; SEXUAL BEHAVIOR; STATISTICAL ANALYSIS;

ANALYSIS OF VARIANCE; ANIMALS; ESTROGEN ANTAGONISTS; ESTRUS; EVALUATION STUDIES; FEMALE; GESTATIONAL AGE; MALE; PIPERIDINES; PREGNANCY; RALOXIFENE; RATS; RECEPTORS, ESTROGEN; REPRODUCTION; SEXUAL BEHAVIOR, ANIMAL;

EID: 0032081162     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(98)00005-7     Document Type: Article

References (44)

1. Sato M, Glasebrook AL, Bryant HU. Raloxifene a selective estrogen receptor modulator . J Bone Miner Met. 12:(Suppl. 2):1994;S9-S20.
2. Jordan VC. Biochemical pharmacology of antiestrogen action. Pharmacol Rev. 36:1984;245-276.
3. Schwartz NB. Acute effects of ovariectomy on pituitary LH, uterine weight, and vaginal cornification. Am J Physiol. 207:1964;1251-1259.
4. Ferin M, Tempone A, Zimming PE, Vande Wiele RL. Effect of antibodies to 17β-estradiol and progesterone on the estrous cycle of the rat. Endocrinology. 85:1969;1070-1083.
5. Neill JD, Freeman ME, Tillson SA. Control of the proestrus surge of prolactin and luteinizing hormone secretion by estrogens in the rat. Endocrinology. 89:1971;1448-1453.
6. Labhsetwar AP. Role of estrogens in ovulation a study using the estrogen-antagonist, I.C.I. 46,474 . Endocrinology. 87:1970;542-551.
7. Labhsetwar AP. The role of oestrogens in spontaneous ovulation evidence for positive oestrogen feedback in the 4-day oestrous cycle . J Endocrinol. 47:1970;481-493.
8. Shirley B, Wolinsky J, Schwartz NB. Effects of a single injection of an estrogen antagonist on the estrous cycle of the rat. Endocrinology. 82:1968;959-968.
9. Holtkamp DE, Greslin JG, Root CA, Lerner LJ. Gonadotrophin inhibiting and anti-fecundity effects of chloramiphene. Proc Soc Exp Biol Med. 105:1960;197-201.
10. Clark JH, Markaverich BM. The agonistic-antagonistic properties of clomiphene a review . Pharmacol Ther. 15:1982;467-519.
11. Barnes LE, Meyer RK. Effects of ethamoxytriphetol, MRL-37, and clomiphene on reproduction in rats. Fertil Steril. 13:1962;472-480.
12. Schally AV, Carter WH, Parlow AF, Saito M, Arimura A, Bowers CY, Holtkamp DE. Alteration of LH and FSH release in rats treated with clomiphene or its isomers. Am J Obstet Gynecol. 107:1970;1156-1167.
13. Simard J, Labrie F. Keoxifene shows pure antiestrogenic activity in pituitary gonadotrophs. Mol Cell Endocrinol. 39:1985;141-144.
14. Bowman SP, Leake A, Miller M, Morris ID. Agonist and antagonist activity of en-clomiphene upon oestrogen-mediated events in the uterus, pituitary gland and brain of the rat. J Endocrinol. 88:1981;367-374.
15. Harper MJK, Walpole AL. A new derivative of triphenylethylene effect on implantation and mode of action in rats . J Reprod Fertil. 13:1967;101-119.
16. Black LJ, Jones CD, Falcone JF. Antagonism of estrogen action with a new benzothiophene derived antiestrogen. Life Sci. 32:1983;1031-1036.
17. Sato M, Rippy MK, Bryant HU. Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats. FASEB J. 10:1996;905-912.
18. Clarke DO, Griffey KI, Buelke-Sam JL, Francis PC. The selective estrogen receptor modulator, raloxifene reproductive assessments following preimplantation exposure in mated female rats . Reprod Toxicol. 12:1998;247-259.
19. Byrd RA, Francis PC. The selective estrogen receptor modulator, raloxifene Segment II studies in rats and rabbits . Reprod Toxicol. 12:1998;261-270.
20. Buelke-Sam J, Cohen I, Wierda D, Griffey K. The selective estrogen modulator, raloxifene a Segment II/III delivery study in rats . Reprod Toxicol. 12:1998;271-288.
21. Salewski E. Farbemethoden zum makroskopischer Nachweis von Implantationsstellen am Uterus der Ratte. [Staining method for a macroscopic test for implantation points in the uterus of the rat]. Naunyn-Schmiedebergs Arch Exp Pathol Pharmakol. 247:1964;367.
22. Weil CS. Selection of the valid number of sampling units and a consideration of their combination in toxicological studies involving reproduction, teratogenesis, or carcinogenesis. Fd Cosmet Toxicol. 8:1970;177-182.
23. Haseman JK, Hogan MS. Selection of the experimental unit in teratology studies. Teratology. 12:1975;165-172.
24. Gaylor DW. Methods and concepts of biometrics applied to teratology. In: Wilson JG, Fraser FC, eds. Handbook of teratology. New York: Plenum Press; 1978;4:429-44.
25. Buelke-Sam J, Holson JF, Nelson CJ. Blood flow during pregnancy in the rat II. Dynamics of and litter variability in uterine flow . Teratology. 26:1982;279-288.
26. Buelke-Sam J, Nelson CJ, Byrd RA, Holson JF. Blood flow during pregnancy in the rat I. Flow patterns to maternal organs . Teratology. 26:1982;269-277.
27. Buelke-Sam J, Byrd RA, Nelson CJ. Blood flow during pregnancy in the rat III. Alterations following mirex treatment . Teratology. 27:1983;401-410.
28. ® user's guide, version 6, 4th ed. 1989;891-996 SAS Institute, Cary, NC.
29. ® Software: Changes and Enhancements, release 6.0. 1993;SAS Institute, Cary, NC.
30. Sokal RR, Rohlf FJ. Assumptions of analysis of variance. Emmerson R, Kennedy D, Park R. Biometry, the principles and practices of statistics in biologic research. 1969;369-377 WH Freeman, San Francisco.
31. ® user's guide, version 6, 4th ed. 1989;405-517 SAS Institute, Cary, NC.
32. Tukey JW, Ciminera JL, Heys JF. Testing the statistical certainty of a response to increasing doses of a drug. Biometrics. 41:1985;295-301.
33. Armitage P. Test for linear trend in proportions and frequencies. Biometrics. 11:1955;375-386.
34. Koch GG, Landis JR, Freeman JL, Freeman DH, Lehnen RG. A general methodology for the analysis of experiments with repeated measurement of categorical data. Biometrics. 33:1990;133-158.
35. Wade GN, Gray JM, Blaustein JD. Effects of estrogens and antiestrogens on eating behavior, metabolism, and energy balance. Oncology. 7:1993;61-68.
36. Historical control data (1992-1994) for developmental and reproductive toxicity studies using the Crl;CD BR rat. 1995;Charles River Laboratories, Wilmington (MA).
37. Everett JW, Sawyer CH. A 24-hour periodicity in the "LH-release apparatus" of female rats, disclosed by barbituate sedation. Endocrinology. 47:1950;198-218.
38. Huang HH, Meites J. Reproductive capacity of aging female rats. Neuroendocrinology. 17:1975;289-295.
39. Huang HH, Steger RW, Bruni JF, Meites J. Patterns of sex steroid and gonadotropin secretion in aging female rats. Endocrinology. 103:1978;1855-1859.
40. Walker RF, Cooper RL, Timiris PS. Constant estrus role of rostral hypothalamic monoamines in development of reproductive dysfunction in aging rats . Endocrinology. 107:1980;249-255.
41. Singh KB. Induction of polycystic ovarian disease in rats by continuous light. I. The reproductive cycle, organ weights, and histology of the ovaries. Am J Obst Gynec. 103:1969;1078-1083.
42. Newberne JW, Kuhn WL, Elsea JR. Toxicologic studies on clomiphene. Toxic Appl Pharmacol. 9:1966;44-55.
43. Dukes M, Chester R, Yarwood L, Wakeling AE. Effects of a non-steroidal pure antioestrogen, ZM 189,154, on oestrogen target organs of the rat including bones. J Endocrinol. 141:1994;335-341.
44. Brown-Grant K, Davidson JM, Greig F. Induced ovulation in albino rats exposed to constant light. J Endocrinol. 57:1973;7-22.